Table 5.
Most frequent AEs according to the formulation.
| SYSTEM ORGAN CLASS | ADVERSE EVENT | FORMULATION | |||||
|---|---|---|---|---|---|---|---|
| NON EMULSIVE-SC | EMULSIVE-IM | TOTAL | |||||
| # | % | # | % | # | % | ||
| General disorders and administration site conditions | Site reaction | 176 | 42.3 | 27 | 25 | 203 | 38.7 |
| Asthenia | 27 | 6.5 | 5 | 4.6 | 32 | 6.1 | |
| Fever | 26 | 6.2 | 1 | 0.9 | 27 | 5.2 | |
| Chills | 15 | 3.6 | 5 | 4.6 | 20 | 3.8 | |
|
| |||||||
| Nervous system disorders | Headache | 25 | 6 | 4 | 3.7 | 29 | 5.5 |
| Metabolism and nutrition disorders | Anorexia | 4 | 0.9 | 3 | 2.7 | 7 | 1.3 |
| Gastrointestinal disorders | Diarrhea | 2 | 0.4 | 1 | 0.9 | 3 | 0.5 |
| Musculoskeletal and connective tissue disorders | Muscle pain | 3 | 0.7 | 8 | 7.4 | 11 | 2.1 |
| Arthralgia | 5 | 1.2 | 1 | 0.9 | 6 | 1.1 | |
| Other | Other | 133 | 31.9 | 53 | 49.1 | 186 | 35.4 |